UCSD-trained neurologist Jack Schim, MD serves as Senior Partner in Carlsbad at The Neurology Center of Southern California on Hidden Valley Road, where he co-directs the Headache Center of California. His migraine-specific medication regimens, including CGRP monoclonal-antibody prescriptions, are managed through Carlsbad Village Pharmacy, which dispenses the specialty injectables central to modern preventive migraine therapy. He earned his medical degree from the University of California San Diego School of Medicine, completed his internship at Cedars-Sinai Medical Center, and finished his neurology residency at UCSD with subspecialty emphasis on EMG, neuromuscular disease, and stroke. As past president of both the Headache Consortium of the Pacific and the California Neurologic Society, he holds board certification in Neurology and United Council for Neurologic Subspecialties certification in Headache Medicine, with fellowship designations from the American Academy of Neurology and the American Headache Society. Chronic-migraine patients who add cognitive-behavioral pain strategies to their pharmacotherapy can access coordinated psychological care at Worthy Wellness Center in Carlsbad. His highest-complexity clinical work involves serving as a principal investigator in Phase III CGRP-pathway clinical trials—including eptinezumab studies—and performing therapeutic botulinum-toxin injection protocols across 31 standardized cranial and cervical sites for chronic migraine under the PREEMPT paradigm.